REGN Operating Cash Flow (Statement)

Regeneron Pharmaceuticals · Operating Cash Flow (Statement)

REGN logo

REGN Operating Cash Flow (Statement)

Latest reported$4.44B
REGN TTM Cash from Operations (-$17.20M → $4.44B)
High-resolution chart · PNG

REGN operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regeneron Pharmaceuticals Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
4,442,800,000
5,012,700,000
4,978,900,000
5,071,000,000
4,743,500,000
3,953,100,000
4,420,500,000
4,247,400,000
4,070,500,000
4,738,900,000
4,594,000,000
5,224,200,000
4,738,800,000
4,280,800,000
5,014,900,000
5,667,500,000
8,452,200,000
8,514,500,000
7,081,300,000
5,939,800,000
2,271,900,000
2,588,600,000
2,618,100,000
2,174,500,000
2,986,100,000
2,231,000,000
2,430,000,000
2,371,400,000
2,267,000,000
2,473,300,000
2,195,100,000
2,033,237,000
1,995,169,000
1,569,999,000
1,307,100,000
1,118,042,000
1,354,239,000
1,784,308,000
1,473,396,000
1,377,340,000
1,619,164,000
1,477,496,000
1,330,780,000
1,247,132,000
518,600,000
597,181,000
752,435,000
831,041,000
759,175,000
550,927,000
583,648,000
400,052,000
305,215,000
98,674,000
-74,615,000
-218,117,000
-262,470,000
-218,143,000
-141,682,000
-133,064,000
74,340,000
95,765,000
96,344,000
91,639,000
-78,852,000
-72,032,000
-72,230,000
-61,666,000
-93,390,000
-81,388,000
-89,086,000
-2,429,000
28,417,000
18,713,000
27,372,000
29,858,000
25,727,000
8,559,000
23,075,000
-50,075,000
-50,242,000
-58,150,000
-30,296,000
-22,648,000
-11,236,000
34,805,000
-16,909,000
-33,139,000
32,257,000
-25,908,000
-6,133,000
-8,730,000
-94,394,000
-83,276,000
-110,523,000
-97,151,000
-95,188,000
-74,977,000
-57,320,000
-43,436,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.